- US Capitol Capsule: Rare disease research hopeful, but therapy success remains low
- Vaccinations next religious target if 'Hobby Lobby' prevails, legal experts warn
- Brain research, antimicrobial resistance among Obama FY15 priorities
- ICH plan to reduce rat carcinogenicity studies moves into new phase
ANALYSIS Other Informa Analysis
- The man behind Vertex’s quest to conquer cystic fibrosis: Jeffrey Leiden
- UCB's Lode Dewulf: 'We can and should talk to patients'